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Objectives: To determine verbal intelligence and spoken
language of children with phenylketonuria and to study the effect
of age at diagnosis and phenylalanine plasma level on these
abilities.
Design: Cross-sectional.
Setting: Children with phenylketonuria were recruited from
pediatric hospitals in 2012. Normal control subjects were
recruited from kindergartens in Tehran.
Participants: 30 phenylketonuria and 42 control subjects aged 4-
6.5 years.  Skills were compared between 3 phenylketonuria
groups categorized by age at diagnosis/treatment, and between
the phenylketonuria and control groups.
Main outcome measures: Scores on Wechsler Preschool and
Primary Scale of Intelligence for verbal and total intelligence, and
Test of Language Development-Primary, third edition for spoken
language, listening, speaking, semantics, syntax, and
organization.
Results: The performance of control subjects was significantly
better than that of early-treated subjects for all composite
quotients from Test of Language Development and verbal
intelligence (P <0.001). Early-treated subjects scored significantly
higher than the two groups of late-treated subjects for spoken
language (P =0.01), speaking (P =0.04), syntax (P =0.02), and
verbal intelligence (P =0.019). There was a negative correlation
between phenylalanine level and verbal intelligence (r= –0.79) in
early-treated subjects and between phenylalanine level and
spoken language (r= –0.71), organization (r= –0.82) and
semantics (r= –0.82) for late-treated subjects diagnosed before
the age one year.
Conclusion: The study confirmed that diagnosis of newborns
and control of blood phenylalanine concentration improves verbal
intelligence and spoken language scores in phenylketonuria
subjects.
Keywords: Development, Management, Outcome,
Pheylalanine.
The prevalence of phenylketonuria (PKU) ishigh in Iran [1,2]. Elevated levels ofphenylalanine (Phe) in plasma cause mentalretardation, seizures, behavioral problems, and
delay in motor and language development [3,4].
Although early-treated children with PKU have been
found to be of average intelligence, they have shown
differences in cognitive function with normally
developing peers [5-7]. The academic and cognitive
functions of children with PKU are significantly lower
than age–matched controls [8,9].
Some investigations have reported conflicting results
for language development in early-treated PKU children
[10-13]. Although language problems have been reported
[10], some studies do not confirm language delay in
children with PKU [11,12]. A relationship between
cognitive function, verbal ability and blood
Phenylalanine level has been demonstrated [6,11,14].
Early and consistent dietary therapy for PKU has been
shown to increase the IQ of afflicted children [15-17].
The present study investigated the effect of age at
diagnosis, treatment onset, and Phenylalanine
concentration on language development.
METHODS
In this cross-sectional study, children diagnosed with
PKU aged 4-6.5 years were recruited from three pediatric
hospitals in Tehran. All enrolled patients had been
assessed for one year (2012-13). It was observed during
assessment that the late-treated group was heterogeneous.
In order to produce more homogenous groups, the
children were placed into one of three groups based on
age at diagnosis: early-treated PKU subjects (diagnosed
by newborn screening), late-treated PKU subjects
(diagnosed before the age of one year) and late-treated
PKU subjects (diagnosed after age one). The age at
diagnosis, treatment onset and blood Phe level were taken
from patient clinical records
Inclusion criteria for subjects were blood Phe higher
than 6 mg% in the first stage of diagnosis [18], treatment
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only by control of Phenylalanine, normal hearing,
Intelligence Quotient (IQ) above 50, native speaker of
Farsi, and able to undergo verbal testing (nonverbal
patients were excluded). The average blood Phe levels
were calculated for the six months prior to onset of the
study. A level of Phe ≤6 mg% indicated strict dietary
control of PKU [18].
An audiologist assessed hearing by Otoacoustic
emissions (OtoRead Handheld OAE device;
Interacoustics). Pure tone audiometric screening was
carried out bilaterally for 25 dB HL ISO at 500, 1000,
2000 and 4000 Hz. A psychologist assessed verbal
intelligence and total intelligence using the validated and
standardized Farsi version of the Wechsler Preschool and
Primary Scale of Intelligence (WPPSI) [19]. WPPSI sub-
tests used for assessment of verbal intelligence were
information, vocabulary, arithmetic, comprehension, and
similarities. A speech therapist assessed language skills of
subjects using the validated and standardized Farsi
version of the Test of Language Development-Primary,
third edition (TOLD-P: 3) [20]. The main TOLD-P: 3
subtests used were: Picture vocabulary: evaluates
understanding of the meaning of spoken words;
Relational vocabulary: evaluates understanding of the
relationship between two spoken words and ability to
explain the relationship orally; Oral vocabulary:
evaluates the skill in relating oral meanings of words
spoken by the examiner; Syntactic understanding:
evaluates the skill to understand the meaning of
sentences; Sentence imitation: evaluates the skill to
reproduce sentences spoken by the examiner; and
Morphological completion: evaluates the skill to
recognize, comprehend, and use usual morphological
forms.
Several subtests were combined to develop
composite scores for semantics, syntax, listening,
organizing, speaking, and spoken language. The Farsi
version of TOLD-P: 3 utilizes standard scores with a
mean of 100 and SD of 15 for composites and a mean of
10 and SD of 3 for its subtests.
Children with apparently normal development were
selected as control group randomly from kindergartens in
Tehran and were matched with the PKU subjects for age,
gender, and level of mother’s education. Their hearing
and IQ were tested to be in normal ranges and they were
native speakers of Farsi.
All procedures were in accordance with the ethical
standards of the Committee for Ethical Study of Human
Subjects at Tehran University of Medical Sciences and
with the Helsinki Declaration. The purpose of the study
was explained to the parents of the subjects. The parents
of all PKU and control subjects signed written informed
consent forms before participation in the study.
Statistical analysis: The normal distribution of data was
assessed using the Kolmogorov-Smirnov test. One way
ANOVA and Tukey honestly significant difference
(HSD) test in post-hoc multiple comparisons were used to
compare the composite quotients from TOLD-P:3 and
verbal IQ independently for the PKU and control groups.
The Spearmen correlation used to detect relationships
between mean blood Phe levels and composite quotients
of TOLD-P: 3 and verbal IQ and to find the relationship
between the spoken language quotient with total IQ and
verbal IQ (P<0.05).
RESULTS
A total of 42 PKU patients were assessed for the study,
and a similar number of controls were selected. Twelve
PKU patients were excluded. Their age at diagnosis was
between 8 to 24 months. One had hearing loss, 1 was
diagnosed with autism, and 10 were severely
intellectually disabled and nonverbal. The 30 PKU
subjects included 13 late-treated subjects diagnosed
before age one, 9 late-treated diagnosed after age one,
and 8 early-treated. The mean (SD) age of early treated,
late treated <1 year age, later treated ≥1 year age and
control groups was 51.1 (8.04), 58.3 (8.87), 68.8 (9.25)
and 59.6 (10.81), respectively.  Phe levels ≤6 mg were
seen in 50%, 41.7% and 46.2% of the three study group,
respectively. Treatment for all PKU subjects had begun
when the disorder was diagnosed. The lowest age at
diagnosis was newborn and the highest was 26 months.
All late-treated children but none of the early-treated
subjects had received rehabilitation. The mean Phe level
in the subjects in the treatment groups was 2.50 to 14.5
mg%.
Table I shows the trend of mean for verbal and total
IQ and all composite quotients.  There were significant
differences between all PKU groups and the control
group for verbal and total IQ and all composite quotients
(P<0.001). The mean of spoken language (P=0.01),
speaking (P=0.04), and syntax (P=0.02) were
significantly higher in early-treated subjects compared to
late-treated subjects diagnosed before age one year.  The
mean of all composite quotients were significantly higher
in early-treated subjects compared to late-treated subjects
diagnosed after age one year (P≤0.002). A significant
difference was observed between the two groups of late-
treated subjects for all composite quotients (P≤0.04),
except organizing.
The results of Phe level versus composite quotients
for TOLD-P: 3 showed significant negative correlations
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between Phe level and the spoken language, organizing
and semantics quotients for late-treated PKU subjects
diagnosed before age one year. There was no significant
correlation between Phe level and composite quotients in
early-treated PKU subjects and late-treated PKU subjects
diagnosed after age one. The relation between verbal IQ
and blood Phe level showed a significant negative
correlation in early-treated PKU subjects. This
correlation was not observed for the late-treated PKU
groups (Table II).
There were significant correlations between total IQ
and spoken language quotient for the control group (r=
0.54, P<0.001) and late-treated PKU groups (r = 0.68,
P<0.001). There was no significant correlation for the
early-treated PKU group (r = 0.29, P=0.49).
A significant correlation was observed between
verbal IQ and spoken language quotient for the control
group (P<0.001) and late-treated PKU groups (P= 0.02).
There was no significant correlation for the early-treated
PKU group (P= 0.38).
DISCUSSION
We found verbal IQ for all PKU groups to differ from that
of the control group. The composite quotients for TOLD-
P:3 showed that the performance of the early-treated group
was lower than average, the late-treated group diagnosed
before age one performed poorly, and late-treated group
diagnosed after age one performed very poorly for
language skills. This study did not show a consistent
relationship between Phe level and language performance
using TOLD-P:3 and verbal IQ.
The present study had some limitations. The first was
that there has been little study of language abilities in
children treated late for PKU, because most countries
now test for the condition in newborns. This means that it
is was not possible to compare the results of the present
study with those of previous studies to assess language
impairment in late-treated PKU subjects. The second
limitation was not being able to test for serum Phe
concentration on the day of assessment. The most recent
assessment time was up to six months prior to onset of the
TABLE I   MEAN (SD) RESULTS OF INTELLIGENCE AND LANGUAGE TESTING OF STUDY POPULATION
Variables Control Early-treated *Late-treated (<1y) *Late-treated(>1y)
Spoken Language 99.55(6.35) 83.37(8.53) 70.44(14.13) 56(8.65)
Listening 98.55(7.07) 86.62(9.15) 78.33(10.98) 65.78(7.61)
Speaking 98.95(6.84) 84.62(5.26) 74(11.64) 64.7(9.95)
Semantics 100.95(6.5) 88.37(7.69) 78.78(14.74) 98.85(9.98)
Organizing 99.69(8.63) 82.37(11.1) 70.67(14.42) 64.92(11.3)
Syntax 97.26(7.59) 80.25(10.09) 68.11(10.94) 57.68(8.68)
Verbal IQ 108.67(9.1) 92.12(13.79) 77.22(13.29) 64.92(8.94)
Total IQ 108.24(99.45) 88.78(12.37) 72.33(14.41) 60.69(7.85)
Values are expressed as Mean (SD), P <0.001; IQ by Wechsler Preschool and primary scale of intelligence and Language testing by Test of
Language Development, 3rd edition.
*Late treated subjects diagnosed before or after 1 year of age.
TABLE II  RELATION BETWEEN PHENYLALANINE LEVEL AND LANGUAGE ABILITY IN CHILDREN WITH PHENYLKETONURIA
Mean blood Phe level
Early-treated *Late-treated *Late-treated
Variables (n=8) (<1y) (n=9) (>1y) (n=13)
Spoken language -0.143 (0.736) -0.711(0.032)$ 0.144 (0.640)
Listening 0.122 (0.774) -0.531(0.141) 0.537(0.059)
Speaking -0.209 (0.620) -0.636 (0.066) -0.014 (0.963)
Semantics 0.193 (0.647) -0.817 (0.007)# 0.151(0.623)
Organizing -0.301 (0.468) -0.814 (0.008)# -0.252 (0.406)
Syntax -0.216 (0.608) -0.636 (0.066) -0.144 (0.640)
Verbal IQ -0.786 (0.021)# -0.269 (0.484) -0.024 (0.938)
$P<0.05, #P<0.01; *Late treated subjects diagnosed before or after 1 year of age.
INDIAN  PEDIATRICS 400 VOLUME 52__MAY 15, 2015
SOLEYMANI, et al. LANGUAGE IN CHILDREN WITH PHENYLKETONURIA
study to calculate mean blood Phe level.
The present results support the findings of previous
researchers [5,6,9] who reported that early diagnosis and
intervention prevents mental retardation.  The spoken
language results demonstrated that this metabolic
disorder affected language even in subjects who were
diagnosed early. These results  conflict with the findings
of Melnick, et al. [10], Michel, et al. [11] and Ozanne, et
al. [21]. They found no pattern of linguistic deficit in
early-treated subjects. Zartler and Sassaman [12] found
that language skills in early-treated children were in the
average range. The source of the disagreement with the
findings of the present study apparently stems for the
different aspects of language that were assessed.  We
found that subjects with PKU were more vulnerable to
problems with organizing than for other language skills.
This may have been related to the type of the tasks that
were used for assessment. These tasks involved memory
and semantic clustering, which are related to executive
functioning [22]. These results must be interpreted with
some caution because the executive function was not
measured as extensively as in other studies [23,24];
however, it appears that children with PKU experience
difficulty with executive functioning.
The findings on total IQ in late-treated children
agreed with the findings of other researchers [3,14];
however, no study was found that investigated language
skills in such children. A clear deficiency in intelligence
and language from early stages of development is
illustrated by the findings of the late-treated subjects for
the relationship between verbal IQ and the spoken
language quotient. The reason that most previous studies
did not find significant differences between normally
developing and early-treated PKU subjects probably
stems from the usage of verbal IQ as a scale for language
assessment.
The results correspond to those of previous studies
[11,14] that increased blood Phe levels decreased verbal
IQ in early-treated children. Ozanne, et al. [21] did not
report a consistent relationship between language skills,
cognitive abilities, or dietary control ratings in early-
treated children. The relationship between Phe level and
organizing, spoken language ability, and semantics in
late-treated subjects diagnosed before age one year
suggests that these skills can improve with strict control
of Phe level. This result confirms that strict dietary
control is necessary for late-treated children.
The results of the present study suggest that
authorities in developing countries must be diligent in
carrying out newborn screening and education of families
with children afflicted with PKU about dietary control.
More research focused on language assessment is needed
to better understand the mechanism of language
impairment, to investigate causality and for continued
longitudinal follow-up.
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